Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A RETROspective Study of the Combination of Pyrimidine Nucleos(t)Ides in Patients With Thymidine Kinase 2 Deficiency (TK2)

NCT03701568 is registered in ClinicalTrials.gov with Zogenix MDS, Inc. as lead sponsor.

NCT NCT03701568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03701568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A RETROspective Study of the Combination of Pyrimidine Nucleos(t)Ides in Patients With Thymidine Kinase 2 Deficiency (TK2)
Lead sponsor
Zogenix MDS, Inc.
Phase
Observational
Overall status
Completed
Start date
November 19, 2018
Completion date
May 31, 2019
Enrollment
38 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

thymidine kinase 2 (tk2)